Yifang Huang

USPTO Granted Patents = 16 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 9 (Patent Applications = 10)

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 16(Granted Patents)

Company Filing History:

7 out of 2,076

Janssen Pharmaceutica Nv

patents

6 out of 8

Lieber Institute, Inc.

patents

4 out of 3,682

The Johns Hopkins University

patents

4. 3 out of 3

Lieber Institute for Brain Development

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12234221 - Pyridine carboxamide compounds for inhibiting NAV1.8 (2025-02-25),

2. 12049467 - Substituted benzopyrazolo[1,5-a][1,4]diazepines as GABA positive allosteric modulators (2024-07-30),

3. 11136322 - Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system (2021-10-05),

4. 10934283 - COMT inhibiting methods and compositions (2021-03-02),

5. 10844070 - Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system (2020-11-24),

6. 10479790 - COMT inhibiting methods and compositions (2019-11-19),

7. 10266534 - Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system (2019-04-23),

8. 10035799 - COMT inhibiting methods and compositions (2018-07-31),

9. 9951057 - COMT inhibiting methods and compositions (2018-04-24),

10. 8686152 - 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (DPP-1) (2014-04-01),

11. 8633322 - Alkynyl derivatives useful as DPP-1 inhibitors (2014-01-21),

12. 8383637 - 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) (2013-02-26),

13. 7932261 - Macrocycle derivatives useful as inhibitors of β-secretase (BACE) (2011-04-26),

14. 7868022 - 2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE) (2011-01-11),

15. 7786116 - 2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE) (2010-08-31),

Title: The Innovations of Yifang Huang: Pioneering Advances in Pharmaceutical Chemistry

Introduction

Yifang Huang, located in Lansdale, Pennsylvania, is a distinguished inventor known for her significant contributions to pharmaceutical chemistry. With an impressive portfolio of 16 patents, Huang has been instrumental in developing novel compounds that target various medical conditions. Her work not only showcases her inventiveness but also her commitment to improving healthcare through innovative solutions.

Latest Patents

Among her latest patents, Huang has developed pyridine carboxamide compounds designed for inhibiting NaV1.8. These compounds are critical in formulating methods to treat conditions, diseases, or disorders associated with increased NaV1.8 activity or expression. Additionally, she has disclosed substituted benzopyrazolo[1,5-a][1,4]diazepines that act as positive allosteric modulators of GABA-A receptors. These innovative compounds selectively target the peripheral nervous system and organs without substantially crossing the blood-brain barrier, providing therapeutic benefits for systemic diseases where modulation of GABA-A receptors is necessary.

Career Highlights

Yifang Huang has contributed her expertise to reputable companies such as Janssen Pharmaceutica and the Lieber Institute, Inc. Her significant experience in these organizations has enabled her to advance her research and innovation in pharmaceutical development, leading to her successful patent acquisitions.

Collaborations

Throughout her career, Huang has collaborated with notable professionals including James C. Barrow and Allen B. Reitz. These collaborations have played a vital role in expanding her research capabilities and enhancing the quality of her inventions.

Conclusion

Yifang Huang stands out as an inspiring inventor, making remarkable strides in pharmaceutical chemistry. Her dedication to innovation is evident in her numerous patents and impactful collaborations. With a focus on developing treatments that address significant medical challenges, Huang continues to be a leading figure in her field, paving the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.